NO962848D0 - Monohydrat av (E)-2'-deoksy-2'-(fluormetylen)cytidin - Google Patents

Monohydrat av (E)-2'-deoksy-2'-(fluormetylen)cytidin

Info

Publication number
NO962848D0
NO962848D0 NO962848A NO962848A NO962848D0 NO 962848 D0 NO962848 D0 NO 962848D0 NO 962848 A NO962848 A NO 962848A NO 962848 A NO962848 A NO 962848A NO 962848 D0 NO962848 D0 NO 962848D0
Authority
NO
Norway
Prior art keywords
fluoromethylene
cytidine
deoxy
monohydrate
neoplastic
Prior art date
Application number
NO962848A
Other languages
English (en)
Other versions
NO306409B1 (no
NO962848L (no
Inventor
Richard E Donaldson
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO962848D0 publication Critical patent/NO962848D0/no
Publication of NO962848L publication Critical patent/NO962848L/no
Publication of NO306409B1 publication Critical patent/NO306409B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO962848A 1994-01-07 1996-07-05 Monohydrat av (E)-2'-deoxy-2'-(fluormethylen)cytidin NO306409B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17895294A 1994-01-07 1994-01-07
PCT/US1994/014648 WO1995018815A1 (en) 1994-01-07 1994-12-13 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine

Publications (3)

Publication Number Publication Date
NO962848D0 true NO962848D0 (no) 1996-07-05
NO962848L NO962848L (no) 1996-09-06
NO306409B1 NO306409B1 (no) 1999-11-01

Family

ID=22654587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962848A NO306409B1 (no) 1994-01-07 1996-07-05 Monohydrat av (E)-2'-deoxy-2'-(fluormethylen)cytidin

Country Status (20)

Country Link
EP (1) EP0738273B1 (no)
JP (1) JPH09511227A (no)
KR (1) KR100330328B1 (no)
CN (1) CN1043231C (no)
AT (1) ATE186732T1 (no)
AU (1) AU684604B2 (no)
CA (1) CA2179987C (no)
DE (1) DE69421721T2 (no)
DK (1) DK0738273T3 (no)
ES (1) ES2141330T3 (no)
FI (1) FI114396B (no)
GR (1) GR3032614T3 (no)
HU (1) HU217849B (no)
IL (1) IL112242A (no)
MX (1) MX9500363A (no)
NO (1) NO306409B1 (no)
NZ (1) NZ279030A (no)
TW (1) TW397838B (no)
WO (1) WO1995018815A1 (no)
ZA (1) ZA9512B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2222614T3 (es) 1997-11-12 2005-02-01 Mitsubishi Chemical Corporation Derivados de purina y medicina que los contiene como ingrediente activo.
CN1160355C (zh) 1999-05-11 2004-08-04 三菱化学株式会社 嘌呤衍生物二水合物、含有该化合物作为有效成分的药物及其制备中间体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA898567B (en) * 1988-11-15 1990-08-29 Merrell Dow Pharma Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine,uridine and guanosine derivatives
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶
HU217963B (hu) * 1992-05-12 2000-05-28 Merrell Dow Pharmaceuticals Inc. Eljárás ribonukleotid-reduktáz inhibitorok előállítására

Also Published As

Publication number Publication date
ZA9512B (en) 1995-09-11
DE69421721T2 (de) 2000-04-27
WO1995018815A1 (en) 1995-07-13
HU217849B (hu) 2000-04-28
ES2141330T3 (es) 2000-03-16
NZ279030A (en) 1997-05-26
EP0738273A1 (en) 1996-10-23
FI962769A0 (fi) 1996-07-05
MX9500363A (es) 1998-04-30
DK0738273T3 (da) 2000-04-17
HU9601848D0 (en) 1996-09-30
KR100330328B1 (ko) 2002-12-05
TW397838B (en) 2000-07-11
IL112242A0 (en) 1995-03-30
AU1553295A (en) 1995-08-01
DE69421721D1 (de) 1999-12-23
IL112242A (en) 2000-08-31
CA2179987A1 (en) 1995-07-13
CA2179987C (en) 1999-01-19
CN1043231C (zh) 1999-05-05
EP0738273B1 (en) 1999-11-17
CN1141045A (zh) 1997-01-22
ATE186732T1 (de) 1999-12-15
NO306409B1 (no) 1999-11-01
JPH09511227A (ja) 1997-11-11
FI114396B (fi) 2004-10-15
AU684604B2 (en) 1997-12-18
GR3032614T3 (en) 2000-05-31
HUT75055A (en) 1997-03-28
NO962848L (no) 1996-09-06
FI962769A (fi) 1996-07-05

Similar Documents

Publication Publication Date Title
CA2002648A1 (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
SE9500566D0 (sv) L-plate
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
EP0347852A3 (en) Novel neplanocin derivatives
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
MY124071A (en) Treatment of viral disease in swine
NO306409B1 (no) Monohydrat av (E)-2'-deoxy-2'-(fluormethylen)cytidin
BR9811643A (pt) Suplementação quìmica de osso
DK0625158T3 (da) Terapeutiske nucleosider af 2',3'-dideoxy-3'-fluorpurinrækken
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
DE69836087D1 (de) Kortikalknochenimplantat für wirbelfusion nach smith-robinson
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
DK0459176T3 (da) Oligophosphater med antiviral virkning
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
SE9403861D0 (sv) Novel medicinal use
AR015724A1 (es) La utilizacion de un inhibidor del intercambiador entre na+ y h+ para la preparacion de un medicamento destinado al tratamiento o a la profilaxia deenfermedades del sistema nervioso central.
ES2085023T3 (es) Procedimientos para la produccion de zidovudina.
ITMI941492A0 (it) Procedimento per la preparazione di buspirone ad alta purezza e del suo idrocoloruro
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
BR9906931A (pt) Triazepinonas, processo para sua preparação e sua aplicação terapêutica
ITCA950008A0 (it) Impiego di combinaqzioni di analoghi di nucleosidi nella terapia delleinfezioni dell'aids.
UA22189A (uk) Іі-кабетоксифеhілакоhітімід, який виявляє активhість відhосhо вірусу везикулярhого стоматиту та вірусу простого герпесу
ITCA950010A0 (it) Combinazioni di pirrolobenzotiazepine con analoghi di nucleosidi per la terapia dell'aids.